1-18 of 18
arm
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Risk of pulmonary emboli after removal of an upper extremity central catheter associated with a deep vein thrombosis

Clinical Trials & Observations
Damon E. Houghton, Henny Heisler Billett, Manila Gaddh, Oluwatomiloba Onadeko, Gemlyn George, Tzu-Fei Wang, Thein H. Oo, Mingen Feng, Mahua Dasgupta, Michael Jaglal, Michael B. Streiff, Pippa Simpson, Radhika Gali, Lisa Baumann Kreuziger
Journal: Blood Advances
Blood Adv (2021) 5 (14): 2807–2812.
https://doi.org/10.1182/bloodadvances.2021004698
Published: 2021
Includes: Supplemental data
Journal Articles

Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance)

Clinical Trials & Observations
Alison R. Walker, Guido Marcucci, Jun Yin, William Blum, Wendy Stock, Jessica Kohlschmidt, Krzysztof Mrózek, Andrew J. Carroll, Ann-Kathrin Eisfeld, Eunice S. Wang, Sawyer Jacobson, Jonathan E. Kolitz, Mohan Thakuri, Grerk Sutamtewagul, Ravi Vij, Robert K. Stuart, John C. Byrd, Clara D. Bloomfield, Richard M. Stone, Richard A. Larson
Journal: Blood Advances
Blood Adv (2021) 5 (13): 2775–2787.
https://doi.org/10.1182/bloodadvances.2021004233
Published: 2021
Includes: Supplemental data
Journal Articles

Low-dose decitabine for refractory prolonged isolated thrombocytopenia after HCT: a randomized multicenter trial

Clinical Trials & Observations
Yaqiong Tang, Jia Chen, Qifa Liu, Tiantian Chu, Tingting Pan, Jianying Liang, Xue Feng He, Feng Chen, Ting Yang, Xiao Ma, Xiaojin Wu, Shaoyan Hu, Xingyu Cao, Xiaohui Hu, Jiong Hu, Yuejun Liu, Jiaqian Qi, Yueping Shen, Changgeng Ruan, Yue Han, Depei Wu
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1250–1258.
https://doi.org/10.1182/bloodadvances.2020002790
Published: 2021
Includes: Supplemental data
Journal Articles

A randomized phase 2/3 study of R-CHOP vs CHOP combined with dose-dense rituximab for DLBCL: the JCOG0601 trial

Clinical Trials & Observations
Ken Ohmachi, Tomohiro Kinoshita, Kensei Tobinai, Gakuto Ogawa, Tomonori Mizutani, Nobuhiko Yamauchi, Noriko Fukuhara, Toshiki Uchida, Kazuhito Yamamoto, Kana Miyazaki, Norifumi Tsukamoto, Shinsuke Iida, Takahiko Utsumi, Isao Yoshida, Yoshitaka Imaizumi, Takashi Tokunaga, Shinichiro Yoshida, Yasufumi Masaki, Tohru Murayama, Yoshihiro Yakushijin, Youko Suehiro, Kisato Nosaka, Nobuaki Dobashi, Junya Kuroda, Yasushi Takamatsu, Dai Maruyama, Kiyoshi Ando, Kenichi Ishizawa, Michinori Ogura, Tadashi Yoshino, Tomomitsu Hotta, Kunihiro Tsukasaki, Hirokazu Nagai, the Japan Clinical Oncology Group
Journal: Blood Advances
Blood Adv (2021) 5 (4): 984–993.
https://doi.org/10.1182/bloodadvances.2020002567
Published: 2021
Includes: Supplemental data
Journal Articles

Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial

Clinical Trials & Observations
Catia Simoes, Bruno Paiva, David Martínez-Cuadrón, Juan-Miguel Bergua, Susana Vives, Lorenzo Algarra, Mar Tormo, Pilar Martinez, Josefina Serrano, Pilar Herrera, Fernando Ramos, Olga Salamero, Esperanza Lavilla, Cristina Gil, Jose-Luis Lopez, Maria-Belen Vidriales, Jorge Labrador, Jose-Francisco Falantes, María-José Sayas, Rosa Ayala, Joaquin Martinez-Lopez, Sara Villar, Maria-Jose Calasanz, Felipe Prosper, Jesús F. San-Miguel, Miguel Ángel Sanz, Pau Montesinos
Journal: Blood Advances
Blood Adv (2021) 5 (3): 760–770.
https://doi.org/10.1182/bloodadvances.2020003195
Published: 2021
Includes: Supplemental data
Journal Articles

Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS

Clinical Trials & Observations
Gerwin Huls, Dana A. Chitu, Thomas Pabst, Saskia K. Klein, Georg Stussi, Laimonas Griskevicius, Peter J. M. Valk, Jacqueline Cloos, Arjan A. van de Loosdrecht, Dimitri Breems, Danielle van Lammeren-Venema, Isabelle van Zeventer, Rinske Boersma, Mojca Jongen-Lavrencic, Martin Fehr, Mels Hoogendoorn, Markus G. Manz, Maaike Söhne, Rien van Marwijk Kooy, Dries Deeren, Marjolein W. M. van der Poel, Marie Cecile Legdeur, Lidwine Tick, Yves Chalandon, Emanuele Ammatuna, Sabine Blum, Bob Löwenberg, Gert J. Ossenkoppele
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4267–4277.
https://doi.org/10.1182/bloodadvances.2020002846
Published: 2020
Includes: Supplemental data
Journal Articles

A phase 3 randomized study (HOMER) of ofatumumab vs rituximab in iNHL relapsed after rituximab-containing therapy

Clinical Trials & Observations
David G. Maloney, Michinori Ogura, Noriko Fukuhara, Jaclyn Davis, Janet Lasher, Miguel Izquierdo, Hiya Banerjee, Kensei Tobinai
Journal: Blood Advances
Blood Adv (2020) 4 (16): 3886–3893.
https://doi.org/10.1182/bloodadvances.2020001942
Published: 2020
Journal Articles

Treosulfan-based conditioning is feasible and effective for cord blood recipients: a phase 2 multicenter study

Clinical Trials & Observations
Filippo Milano, Jonathan A. Gutman, H. Joachim Deeg, Eneida R. Nemecek, Joachim Baumgart, Laurel Thur, Ann Dahlberg, Rachel B. Salit, Corinne Summers, Frederick R. Appelbaum, Colleen Delaney
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3302–3310.
https://doi.org/10.1182/bloodadvances.2020002222
Published: 2020
Includes: Supplemental data
Journal Articles

Lenalidomide/rituximab induces high molecular response in untreated follicular lymphoma: LYSA ancillary RELEVANCE study

Clinical Trials & Observations
Marie-Helene Delfau-Larue, Marie-Laure Boulland, Asma Beldi-Ferchiou, Pierre Feugier, Hervé Maisonneuve, Rene-Olivier Casasnovas, François Lemonnier, Gian Matteo Pica, Roch Houot, Loic Ysebaert, Hervé Tilly, Jean-Claude Eisenmann, Steven Le Gouill, Vincent Ribrag, Pascal Godmer, Sylvie Glaisner, Guillaume Cartron, Luc Xerri, Gilles André Salles, Thierry Fest, Franck Morschhauser
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3217–3223.
https://doi.org/10.1182/bloodadvances.2020001955
Published: 2020
Includes: Supplemental data
Journal Articles

Diagnosis of deep vein thrombosis of the upper extremity: a systematic review and meta-analysis of test accuracy

Payal Patel, Cody Braun, Parth Patel, Meha Bhatt, Housne Begum, Wojtek Wiercioch, Jamie Varghese, David Wooldridge, Hani J. Alturkmani, Merrill Thomas, Mariam Baig, Waled Bahaj, Rasha Khatib, Rohan Kehar, Rakesh Ponnapureddy, Anchal Sethi, Ahmad Mustafa, Wendy Lim, Grégoire Le Gal, Shannon M. Bates, Eddy Lang, Marc Righini, Nedaa M. Husainat, Mohamad A. Kalot, Yazan Nayif Al Jabiri, Robby Nieuwlaat, Holger J. Schünemann, Reem A. Mustafa
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2516–2522.
https://doi.org/10.1182/bloodadvances.2019001409
Published: 2020
Includes: Supplemental data
Journal Articles

Grading and management of cytokine release syndrome in patients treated with tisagenlecleucel in the JULIET trial

Clinical Trials & Observations
Stephen J. Schuster, Richard T. Maziarz, Elisha S. Rusch, Junlong Li, James E. Signorovitch, Vadim V. Romanov, Frederick L. Locke, David G. Maloney
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1432–1439.
https://doi.org/10.1182/bloodadvances.2019001304
Published: 2020
Includes: Supplemental data
Journal Articles

Early peripheral clearance of leukemia-associated immunophenotypes in AML: centralized analysis of a randomized trial

Clinical Trials & Observations
Giacomo Gianfaldoni, Francesco Mannelli, Tamara Intermesoli, Sara Bencini, Damiano Giupponi, Giorgio Farina, Ilaria Cutini, Maria Ida Bonetti, Arianna Masciulli, Ernesta Audisio, Dario Ferrero, Chiara Pavoni, Anna Maria Scattolin, Alberto Bosi, Alessandro Rambaldi, Renato Bassan
Journal: Blood Advances
Blood Adv (2020) 4 (2): 301–311.
https://doi.org/10.1182/bloodadvances.2019000406
Published: 2020
Includes: Supplemental data
Journal Articles

Allo-HSCT in transplant-naïve patients with Hodgkin lymphoma: a single-arm, multicenter study

Clinical Trials & Observations
Emma Das-Gupta, Kirsty J. Thomson, Adrian J. C. Bloor, Andrew D. Clark, Stephen Mackinnon, Irfan Kayani, Laura Clifton-Hadley, Pip Patrick, Nadjet El-Mehidi, Anthony Lawrie, Amy A. Kirkwood, Nigel H. Russell, David C. Linch, Karl S. Peggs
Journal: Blood Advances
Blood Adv (2019) 3 (24): 4264–4270.
https://doi.org/10.1182/bloodadvances.2019001016
Published: 2019
Journal Articles

Phase 1b study of the MDM2 inhibitor AMG 232 with or without trametinib in relapsed/refractory acute myeloid leukemia

Clinical Trials & Observations
Harry P. Erba, Pamela S. Becker, Paul J. Shami, Michael R. Grunwald, Donna L. Flesher, Min Zhu, Erik Rasmussen, Haby A. Henary, Abraham A. Anderson, Eunice S. Wang
Journal: Blood Advances
Blood Adv (2019) 3 (13): 1939–1949.
https://doi.org/10.1182/bloodadvances.2019030916
Published: 2019
Journal Articles

Evaluation of event-free survival as a robust end point in untreated acute myeloid leukemia (Alliance A151614)

Clinical Trials & Observations
Jun Yin, Betsy LaPlant, Geoffrey L. Uy, Guido Marcucci, William Blum, Richard A. Larson, Richard M. Stone, Sumithra J. Mandrekar
Journal: Blood Advances
Blood Adv (2019) 3 (11): 1714–1721.
https://doi.org/10.1182/bloodadvances.2018026112
Published: 2019
Includes: Supplemental data
Journal Articles

Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance)

Clinical Trials & Observations
Gail J. Roboz, Sumithra J. Mandrekar, Pinkal Desai, Kristina Laumann, Alison R. Walker, Eunice S. Wang, Jonathan E. Kolitz, Bayard L. Powell, Eyal C. Attar, Wendy Stock, Clara D. Bloomfield, Jessica Kohlschmidt, Krzysztof Mrózek, Duane C. Hassane, Levi Garraway, Judit Jané-Valbuena, Michele Baltay, Adam Tracy, Guido Marcucci, Richard M. Stone, Richard A. Larson
Journal: Blood Advances
Blood Adv (2018) 2 (24): 3608–3617.
https://doi.org/10.1182/bloodadvances.2018023689
Published: 2018
Includes: Supplemental data
Journal Articles

Cyclosporine or steroids as an adjunct to plasma exchange in the treatment of immune-mediated thrombotic thrombocytopenic purpura

Clinical Trials & Observations
Spero R. Cataland, Peter J. Kourlas, Shangbin Yang, Susan Geyer, Leslie Witkoff, Haiwa Wu, Camila Masias, James N. George, Haifeng M. Wu
Journal: Blood Advances
Blood Adv (2017) 1 (23): 2075–2082.
https://doi.org/10.1182/bloodadvances.2017009308
Published: 2017
Journal Articles

Copy number alterations detected as clonal hematopoiesis of indeterminate potential

Koichi Takahashi, Feng Wang, Hagop Kantarjian, Xingzhi Song, Keyur Patel, Sattva Neelapu, Curtis Gumbs, Latasha Little, Samantha Tippen, Rebecca Thornton, Courtney D. DiNardo, Farhad Ravandi, Carlos Bueso-Ramos, Jianhua Zhang, Xifeng Wu, Guillermo Garcia-Manero, P. Andrew Futreal
Journal: Blood Advances
Blood Adv (2017) 1 (15): 1031–1036.
https://doi.org/10.1182/bloodadvances.2017007922
Published: 2017
Includes: Supplemental data